LA THERAPIE CIBLEE EN ONCOLOGIE : CANCER DU SEIN

dc.contributor.advisorEL Mustafa El Fahime
dc.contributor.authorMeryem Chennaq
dc.date.accessioned2023-09-15T13:42:48Z
dc.date.accessioned2026-01-22T13:34:41Z
dc.date.available2023-09-15T13:42:48Z
dc.date.issued2023
dc.description.collaboratorEL Mustafa El Fahime
dc.description.collaboratorYahia Cherrah
dc.description.collaboratorYounes Rahali
dc.description.collaboratorJaouad El Harti
dc.description.collaboratorRachid El Jaoudi
dc.identifier.urihttps://toubkalpreprod.imist.ma/handle/123456789/19321
dc.language.isofr
dc.publisherUniversité Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabatfr_FR
dc.subjectCancer du sein; Thérapies ciblées; Voies de signalisation; Anticorps monoclonauxfr_FR
dc.subject.otherSciences médicales
dc.subject.specificOncologie
dc.titleLA THERAPIE CIBLEE EN ONCOLOGIE : CANCER DU SEINfr_FR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
P0382023.pdf
Size:
2.34 MB
Format:
Adobe Portable Document Format